“Haemonetics” High Efficiency Post-process Filter System for Leucocyte removal from red cells
Taiwan·Risk Class 2·MD·Haemonetics Manufacturing, Inc.·Registered Dec 09, 2016 – Dec 09, 2026Active- Analysis ID
- 6b8a1170997bc5a3ff23a0d2103532d3
- License Form
- Ministry of Health Medical Device Import No. 029160
- Customs Code
- DHA05602916006
- Manufacturer
- Haemonetics Manufacturing, Inc.
- Manufacturer Country
- United States
- Authorized Representative
- HAEMONETICS ASIA INCORPORATED TAIWAN BRANCH (U.S.A.)
- Intended Use
- This product is a container for the collection and processing of blood and blood components for the collection, storage or transportation of blood and its components for further processing.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B9100 Containers for the collection and processing of blood and blood components
- Import Information
- Imported from abroad
- Registration Date
- Dec 09, 2016
- Expiry Date
- Dec 09, 2026
Access comprehensive regulatory information for “Haemonetics” High Efficiency Post-process Filter System for Leucocyte removal from red cells in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6b8a1170997bc5a3ff23a0d2103532d3 and manufactured by Haemonetics Manufacturing, Inc.. The authorized representative in Taiwan is HAEMONETICS ASIA INCORPORATED TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.